Page last updated: 2024-08-23

s-adenosylmethionine and Triple Negative Breast Neoplasms

s-adenosylmethionine has been researched along with Triple Negative Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chammas, R; Chuffa, LGA; Junior, RP; Reiter, RJ; Simão, VA; Sonehara, NM; Zuccari, DAPC1
Cacciapuoti, G; Caraglia, M; Coppola, A; Ilisso, CP; Mosca, L; Porcelli, M; Schiraldi, C; Stellavato, A1

Other Studies

2 other study(ies) available for s-adenosylmethionine and Triple Negative Breast Neoplasms

ArticleYear
Melatonin Regulates the Daily Levels of Plasma Amino Acids, Acylcarnitines, Biogenic Amines, Sphingomyelins, and Hexoses in a Xenograft Model of Triple Negative Breast Cancer.
    International journal of molecular sciences, 2022, Aug-14, Volume: 23, Issue:16

    Topics: Amino Acids; Animals; Biogenic Amines; Carnitine; Heterografts; Hexoses; Humans; Melatonin; Mice; Sphingomyelins; Triple Negative Breast Neoplasms

2022
S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a.
    International journal of molecular sciences, 2020, Dec-30, Volume: 22, Issue:1

    Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; S-Adenosylmethionine; Triple Negative Breast Neoplasms; Up-Regulation

2020